title: Prevention of respiratory syncytial viral infections in late preterm infants.
abstract: RSV prophylaxis is not routine in infant born 33 to 35 weeks gestation. Risk scoring tool can be utilized to identify infants that have significant chance for hospitalization. Premature birth is a leading cause of infant mortality and chronic pulmonary morbidity, therefore prevention of RSV hospitalization though immune prophylaxis in late preterm infants appears attractive.
authors.affiliation: Department of Pediatrics, University of Saskatchewan, Saskatoon, SK, Canada.
authors.forename: Koravangattu
authors.initials: K
authors.lastname: Sankaran
authors.forename: Mila
authors.initials: M
authors.lastname: Kalappurackal
authors.forename: Ben
authors.initials: B
authors.lastname: Tan
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007363:Intensive Care Units, Neonatal; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069455:Palivizumab